Search Results - "Böcskei, Z"

Paraneoplastic ophthalmopathies by Böcskei, Z, Viinikka, E, Dormegny, L, Bigaut, K, Speeg, C

“…Ocular paraneoplastic syndromes are rare conditions that can affect any part of the eye at any age. Thus, every ophthalmologist should be familiar with their…”
Get more information

Prolyl Oligopeptidase: An Unusual β-Propeller Domain Regulates Proteolysis by Fueloep, V, Boecskei, Z, Polgar, L

“…Prolyl oligopeptidase is a large cytosolic enzyme that belongs to a new class of serine peptidases. The enzyme is involved in the maturation and degradation of…”
Get full text

A new potent calmodulin antagonist with arylalkylamine structure: crystallographic, spectroscopic and functional studies by Harmat, Veronika, Böcskei, Zsolt, Náray-Szabó, Gábor, Bata, Imre, Csutor, Andrea S., Hermecz, István, Arányi, Péter, Szabó, Beáta, Liliom, Károly, Vértessy, Beáta G., Ovádi, Judit

“…An arylalkylamine-type calmodulin antagonist, N-(3,3-diphenylpropyl)- N′-[1-R-(3,4-bis-butoxyphenyl)ethyl]-propylene-diamine (AAA) is presented and its…”
Get full text

Ophtalmies paranéoplasiques by Böcskei, Z., Viinikka, E., Dormegny, L., Bigaut, K., Speeg, C.

“…Les ophtalmies paranéoplasiques sont des atteintes oculaires rares qui peuvent toucher l’ensemble des structures oculaires, à tout âge. Par conséquent, tout…”
Get full text

Structures of isobenzofuranone-substituted diexo-norbornane/ene-azetidinones by Böcskei, Z, Sohár, P, Stájer, G

“…The reactions of diexo-norbornane- and -norborneneazetidinones ( 1 and 2) with o-carboxybenzaldehyde ( 3) result in two diastereomeric isobenzofuranone-…”
Get full text

Irbesartan Crystal Form B by Böcskei, Z., Simon, K., Rao, R., Caron, A., Rodger, C. A., Bauer, M.

Get full text

Microbial transformation of β-sitosterol and stigmasterol into 26-oxygenated derivatives by Ambrus, Gábor, Ilkőy, Éva, Jekkel, Antónia, Horváth, Gyula, Böcskei, Zsolt

“…The genetically modified Mycobacterium sp. BCS 396 strain has been used to transform sterols with stigmastane side chain in order to obtain 26-oxidized…”
Get full text

Isostructural Metabolites of Two Anti-Parkinson Drugs by Simon, K., Harmat, V., Török, Z., Böcskei, Z., Hermecz, I.

Get full text

A Bicyclic Cyclopropane Carboxylic Acid Lactone from a Solid-Liquid PTC Reaction by Böcskei, Z., Hell, Z., Finta, Z., Tőke, L., Simon, K.

Get full text

Ipriflavone, an antiostheophorotic agent by Böcskei, Z, Simon, K, Varga, M, Hermecz, I

“…The antiostheophorotic agent ipriflavone [7-(1-methyl-ethoxy)-3-phenyl-4H-1-benzopyran-4-one, C18H16O3] is an important member of the isoflavone family. The…”
Get more information

Glaucopsia after occupational exposure to amines by Wurtz, M, Becmeur, P-H, Chammas, J, Bocskei, Z, Treser, F, Sauer, A, Gaucher, D, Speeg-Schatz, C, Bourcier, T

Get more information

Novel 26-oxygenated products in microbial degradation of ergosterol by Ambrus, Gábor, Jekkel, Antónia, Ilkőy, Éva, Horváth, Gyula, Böcskei, Zsolt

“…In order to investigate the effect of the different stereochemistry of C-24 on the microbial C-26 oxidation of sterol side-chain the genetically modified…”
Get full text

Two antithrombotic quinazolone derivatives by Böcskei, Z, Simon, K, Orfi, L, Kökösi, J

“…The structures of two antithrombotic quinazolone derivatives, 1,2,3,5-tetrahydro-2-benzylimidazo[5,1-b]-quinazolin-5-one, (I), and…”
Get more information

Crystallization of and preliminary X-ray data for the mouse major urinary protein and rat alpha-2u globulin by Böcskei, Z, Findlay, J B, North, A C, Phillips, S E, Somers, W S, Wright, C E, Lionetti, C, Tirindelli, R, Cavaggioni, A

“…Crystals of the mouse major urinary protein (MUP) and rat alpha-2u globulin (AMG) have been grown from solutions of polyethylene glycol 3350 and CdCl2,…”
Get more information

Pheromone binding to two rodent urinary proteins revealed by X-ray crystallography by Böcskei, Zsolt, Groom, Colin R, Flower, Darren R, Wright, Charles E, Phillips, Simon E. V, Cavaggioni, Andrea, Findlay, John B. C, North, Anthony C. T

“…The principal protein excreted in male rat urine, urinary alpha 2-globulin and the homologous mouse protein, major urinary protein, have been well…”
Get full text

Application of protein crystallography in drug design by Böcskei, Z

“…An overview of the application of protein crystallography in drug design is given in the paper. First a few basic principles of the systematic target based…”
Get more information

Crystallization and preliminary X-ray analysis of porcine muscle prolyl oligopeptidase by Böcskei, Zsolt, Fuxreiter, Mónika, Náray-Szabó, Gábor, Szabó, Erika, Polgár, László

“…Prolyl oligopeptidase from pig muscle has been crystallized in complex with an inhibitor, using PEG 8000 and calcium acetate as precipitants. The crystals are…”
Get full text

The three‐dimensional structure of Asp189Ser trypsin provides evidence for an inherent structural plasticity of the protease by Szabó, Erika, Böcskei, Zsolt, Náray‐Szabó, Gábor, Gráf, László

“…Trypsin mutant Asp189Ser, first described by Gráf et al. [Gráf, L., Jancsó, Á., Szilágyi, L., Hegyi, G., Pintér, K., Náray‐Szabó, G., Hepp, J., Medzihradszky,…”
Get full text

Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients by Adriani, Marsilio, Nytrova, Petra, Mbogning, Cyprien, Hässler, Signe, Medek, Karel, Jensen, Poul Erik H, Creeke, Paul, Warnke, Clemens, Ingenhoven, Kathleen, Hemmer, Bernhard, Sievers, Claudia, Lindberg Gasser, Raija Lp, Fissolo, Nicolas, Deisenhammer, Florian, Bocskei, Zsolt, Mikol, Vincent, Fogdell-Hahn, Anna, Kubala Havrdova, Eva, Broët, Philippe, Dönnes, Pierre, Mauri, Claudia, Jury, Elizabeth C

“…Multiple sclerosis (MS) is an autoimmune disease characterized by CNS inflammation leading to demyelination and axonal damage. IFN-β is an established…”
Get full text

SSR182289A, a selective and potent orally active thrombin inhibitor by Altenburger, Jean-Michel, Lassalle, Gilbert Y., Matrougui, Mostapha, Galtier, Daniel, Jetha, Jean-Claude, Bocskei, Zsolt, Berry, Christopher N., Lunven, Catherine, Lorrain, Janine, Herault, Jean-Pascal, Schaeffer, Paul, O'Connor, Stephen E., Herbert, Jean-Marc

“…SSR182289A 1 is the result of a rational optimisation process leading to an orally active thrombin inhibitor. The structure incorporates an original…”
Get full text